Clearside Biomedical Inc. (CLSD) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Clearside Biomedical Inc.

    NASDAQ: CLSD · Real-Time Price · USD
    4.37
    0.30 (7.37%)
    At close: Oct 03, 2025, 3:59 PM
    4.29
    -1.83%
    After-hours: Oct 03, 2025, 07:30 PM EDT

    Clearside Biomedical Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -34.35M -32.48M -32.95M 376K
    Depreciation & Amortization
    		 226K 67K 145K 178K
    Stock-Based Compensation
    		 4.51M 4.2M 4.88M 5.05M
    Other Working Capital
    		 -193K 326K 122K -4.47M
    Other Non-Cash Items
    		 6.59M 9.36M 3.32M -998K
    Deferred Income Tax
    		 n/a n/a n/a n/a
    Change in Working Capital
    		 -1.68M 720K 11.24M -15.34M
    Operating Cash Flow
    		 -24.7M -18.14M -13.37M -10.73M
    Capital Expenditures
    		 -977K -1.78M -246K n/a
    Cash Acquisitions
    		 n/a n/a n/a n/a
    Purchase of Investments
    		 -16.91M n/a n/a n/a
    Sales Maturities Of Investments
    		 17.25M n/a n/a n/a
    Other Investing Acitivies
    		 n/a n/a n/a n/a
    Investing Cash Flow
    		 -638K -1.78M -246K n/a
    Debt Repayment
    		 n/a n/a 30.64M n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 47K -1.25M 129K 499K
    Financial Cash Flow
    		 16.44M 414K 31.33M 23.78M
    Net Cash Flow
    		 -8.9M -19.5M 17.72M 13.05M
    Free Cash Flow
    		 -25.68M -19.91M -13.61M -10.73M

    Add to Watchlist